Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or VSports app下载. mil. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. V体育官网.

Randomized Controlled Trial
. 2016 Feb 5:6:20391.
doi: 10.1038/srep20391.

"V体育安卓版" Mortality prediction in patients with severe septic shock: a pilot study using a target metabolomics approach

Affiliations
Randomized Controlled Trial

Mortality prediction in patients with severe septic shock: a pilot study using a target metabolomics approach (VSports)

Manuela Ferrario (VSports app下载) et al. Sci Rep. .

Abstract

Septic shock remains a major problem in Intensive Care Unit, with high lethality and high-risk second lines treatments. In this preliminary retrospective investigation we examined plasma metabolome and clinical features in a subset of 20 patients with severe septic shock (SOFA score >8), enrolled in the multicenter Albumin Italian Outcome Sepsis study (ALBIOS, NCT00707122). Our purpose was to evaluate the changes of circulating metabolites in relation to mortality as a pilot study to be extended in a larger cohort. Patients were analyzed according to their 28-days and 90-days mortality. Metabolites were measured using a targeted mass spectrometry-based quantitative metabolomic approach that included acylcarnitines, aminoacids, biogenic amines, glycerophospholipids, sphingolipids, and sugars. Data-mining techniques were applied to evaluate the association of metabolites with mortality. Low unsaturated long-chain phosphatidylcholines and lysophosphatidylcholines species were associated with long-term survival (90-days) together with circulating kynurenine. Moreover, a decrease of these glycerophospholipids was associated to the event at 28-days and 90-days in combination with clinical variables such as cardiovascular SOFA score (28-day mortality model) or renal replacement therapy (90-day mortality model). Early changes in the plasma levels of both lipid species and kynurenine associated with mortality have potential implications for early intervention and discovering new target therapy VSports手机版. .

PubMed Disclaimer

Figures

Figure 1
Figure 1. Flow chart, which displays the progress of patient selection from the ALBIOS biobank according to our inclusion/exclusion criteria.
Figure 2
Figure 2
Heat maps of the metabolites (mean Log 2 μM) whose concentrations changed significantly from day 1 (D1) to day 7 (D7) in survivors (S) (a) and non-survivors (NS) (b) both considering mortality at 28 days and 90 days (Wilcoxon test p < 0.05, FDR < 0.15).
Figure 3
Figure 3
Comparison of the absolute differences in metabolite concentrations (μM) from day 1 to day 7 (Delta = D7–D1) in survivors (S) and non-survivors (NS) at 28 days (a) or 90 days (b). Distribution of differences is shown as box-plots, where the central mark is the median concentration, the edges of the box are the 25th and 75th percentiles, the outliers are defined as 1.5 times of interquartile range and highlighted by stars. Each plot represents a different metabolite. (Wilcoxon test p < 0.05, FDR < 0.15).
Figure 4
Figure 4
Elastic Net coefficients built on metabolites concentration at day 1 (a) and day 7 (b) for 28-day and 90 days mortality (c). The MSE computed for the models are 0.21 for (a), 0.26 for (b) and 0.27 for (c).
Figure 5
Figure 5
Elastic Net coefficients built on metabolites concentration and clinical parameters collected at day 7 for 28-day (a) and 90 days mortality (b). The MSE computed for the models are 0.23 for the 28-day one (a) and 0.24 for the 90-day (b). SOFA CARD: cardiovascular SOFA score; SOFA TOT: total SOFA score; MAP: mean arterial pressure; pHv: venous pH; diuresis (ml/die) collected at day 7; RRT: renal replacement therapy administered during the first 7 days of treatment.

V体育2025版 - References

    1. Russell J. A. Management of sepsis. N Engl J Med 355, 1699–713, (2006). - PubMed
    1. Angus D. C. & van der Poll T. Severe sepsis and septic shock. N Engl J Med 369, 840–51, (2013). - PubMed
    1. Cohen J. et al. Sepsis: a roadmap for future research. Lancet Infect Dis 15, 581–614, (2015). - PubMed
    1. Caironi P. et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 370, 1412–21, (2014). - PubMed (V体育官网入口)
    1. Perner A. et al. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 367, 124–34, (2012). - PubMed

Publication types

MeSH terms

V体育ios版 - Associated data